FDA Update
Recently, the FDA issued a statement that prohibits the compounding of certain peptides and peptidomimetics (Ibutamoren, CJC-1295/Ipamorelin, and BPC-157 to name a few). Many peptides and peptidomimetics will no longer be available.
Some pharmacies are continuing to process requests for these peptides and peptidomimetics through October 20, 2023. To request these substances before 4p PST on this date, please call 310-452-3206, respond to this email, or access your patient portal and send a message to “Prescription Refills.”
Best in Health,
Michael Bell
Chief Operating Officer